PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8697482-6	1996	In the control group, dobutamine produced a significant decrease in both end-diastolic and end-systolic volumes, with percent changes from rest to peak of 24 +/- 5% and 29 +/- 5% respectively, and an average increase of 70 +/- 20% in the SBP/ESVI ratio.	Dobutamine	22-32	selenium binding protein 1	Homo sapiens	238-241	
20211301-6	2010	RESULTS: At peak dobutamine infusion, SBP amplification averaged 14.9 mm Hg, with a maximum difference of 43 mm Hg.	Dobutamine	17-27	selenium binding protein 1	Homo sapiens	38-41	
17094270-4	2006	In a pharmacogenetic study composed of 107 subjects, our bivariate model has probed two haplotypes within the beta 2AR candidate gene that exert a significant effect on both SBP and DBP respond to dobutamine.	Dobutamine	197-207	selenium binding protein 1	Homo sapiens	174-177